Skip to main content
SpringerLink
Log in

ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Menona SS, Guruvayoorappan C, Sakthivelc KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clinica Chimica Acta. 2019;491:39–45.

    Article  Google Scholar 

  2. Bosman FC, Carneiro F, Hruban R. WHO classification of tumours: digestive system tumours. WHO. 2019. https://doi.org/10.1111/his.13975.

    Article  Google Scholar 

  3. Shetty S, Thomas P, Ramanan B, et al. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. J Surg Research. 2013;180:97–103.

    Article  CAS  Google Scholar 

  4. Pietrantonio FPF, Mennitto A, et al. Toward the molecular dissection of peritoneal pseudomyxoma. Ann Oncol. 2016;27:2097–103.

    Article  CAS  Google Scholar 

  5. Rufian-Andujar B, Valenzuela-Molina F, Rufian-Peña S, et al. From the Ronnett to the PSOGI classification system for pseudomyxoma peritonei: a validation study. Ann Surg Oncol. 2021;28:2819–27.

    Article  Google Scholar 

  6. Arjona-Sanchez A., Martinez Lopez A, Valenzuela Molina F, et al. A proposal for modification of PSOGI classification according to Ki-67 proliferation index in pseudomyxoma peritonei. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10372-9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Surgical Oncology, Department of Surgery, Reina Sofia University Hospital, Av. Menendez Pidal, s/n, 14004, Cordoba, Spain

    Álvaro Arjona-Sánchez PhD, Francisca Valenzuela-Molina MD, Blanca Rufián-Andújar MD, Lidia Rodríguez-Ortiz MD & Antonio Romero-Ruíz PhD

  2. GE09 Research in Peritoneal and Retroperitoneal Oncological Surgery, Maimonides Biomedical Research, Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain

    Álvaro Arjona-Sánchez PhD, Ana Martínez-López MD, Francisca Valenzuela-Molina MD, Blanca Rufián-Andújar MD, Lidia Rodríguez-Ortiz MD, Melissa Granados-Rodríguez MD & Antonio Romero-Ruíz PhD

  3. Pathology Unit, Reina Sofia University Hospital, Cordoba, Spain

    Ana Martínez-López MD

Authors
  1. Álvaro Arjona-Sánchez PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Martínez-López MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francisca Valenzuela-Molina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Blanca Rufián-Andújar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lidia Rodríguez-Ortiz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Melissa Granados-Rodríguez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Antonio Romero-Ruíz PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Álvaro Arjona-Sánchez PhD.

Ethics declarations

DISCLOSURE

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arjona-Sánchez, Á., Martínez-López, A., Valenzuela-Molina, F. et al. ASO Author Reflections: Towards a Precision Medicine in Pseudomyxoma Peritonei. Ann Surg Oncol 29, 137–138 (2022). https://doi.org/10.1245/s10434-021-10435-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10435-x

Search

Navigation